OTC BB: PKTX

ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine and the biotechnology and cosmetic industries. PKTX is currently in collaboration with major corporations and institutions who have contacted the company about the broad range of applications for AAGP™ products.

For More Information Contact

ProtoKinetix Inc.
Suite 1500 - 885 West Georgia Street
Vancouver, BC
Tel: 604-687-9887
Fax: 604-687-6652
Blair Henderson
Investor Relations
info@protokinetix.com
OTC Financial Network
300 Chestnut Street
Suite 200
Needham, MA 02492
Tel: 781.444.6100 Ext.625
Fax: 781.444.6101
Rick McCaffrey
Investor Relations
rick@otcfn.com

Disclaimer